Sutro Biopharma (STRO) Return on Sales [ROS] (2017 - 2026)
Sutro Biopharma's Return on Sales [ROS] came in at -303.77% for Q2 2026, down 298.52 percentage points from -5.25% a year earlier.
Powered by 
Analysis
Sutro Biopharma (STRO) Return on Sales [ROS] (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Sutro Biopharma reported Return on Sales [ROS] of -126.14%, up 70.11 percentage points year-over-year; for FY2025, it was -154.53%, up 229.81 percentage points from FY2024.
- Return on Sales [ROS] carries a five-year change of +11.80 percentage points (FY2020 to FY2025).
- Going back by year, Return on Sales [ROS] was -384.34% in FY2024 (-326.26 pp), -58.07% in FY2023 (+132.19 pp), -190.26% in FY2022 (-31.04 pp) and -159.22% in FY2021 (+7.11 pp).
- The five-year range for quarterly Return on Sales [ROS] is -797.17% (Q3 2024) to 37.95% (Q4 2023).
- Year-over-year, Return on Sales [ROS] increased in four of the last seven quarters, with an average year-over-year change of -96.80 percentage points.
- The fastest year-over-year change in Return on Sales [ROS] over five years came in Q4 2023 (a gain of 608.17 percentage points), and the weakest in Q3 2024 (a drop of 537.10 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 30.89% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 32.98% |
| 10 | Sutro Biopharma | 175.16 Mn | -500.76 Mn | - | -303.77% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -303.77% |
| Dec 31, 2025 | -326.68% |
| Sep 30, 2025 | -499.94% |
| Jun 30, 2025 | -5.25% |
| Mar 31, 2025 | -393.78% |
| Dec 31, 2024 | -440.66% |
| Sep 30, 2024 | -797.17% |
| Jun 30, 2024 | -189.39% |
| Mar 31, 2024 | -435.05% |
| Dec 31, 2023 | 37.95% |
| Sep 30, 2023 | -260.07% |
| Jun 30, 2023 | -443.52% |
| Mar 31, 2023 | -333.26% |
| Dec 31, 2022 | -570.23% |
| Sep 30, 2022 | -84.34% |
| Jun 30, 2022 | -68.97% |
| Mar 31, 2022 | -663.59% |
| Dec 31, 2021 | -328.85% |
| Sep 30, 2021 | -407.12% |
| Jun 30, 2021 | -34.96% |
API Access
Sutro Biopharma Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=STRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "STRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=STRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();